Trinational Studies in Biotechnology Strasbourg – Freiburg – Basel, three cities, three universities. Together they offer the unique opportunity of studying across the borders. The interdisciplinary diploma course in…

The production of proteins is the most energy-consuming activity of cells. It needs to be tightly regulated, to ensure efficient use of cellular resources. Researchers led by Prof. Mihaela Zavolan at the Biozentrum have now…

The restrictions resulting from the ongoing coronavirus pandemic impact each of us in our daily work. But the crisis also sparks resourcefulness. The Biozentrum Symposium, for example, was completely re-designed and moved to…

“Have the courage to follow your own path.” December 2025 Anna Seelig spent five decades researching side by side with her husband, Joachim Seelig, at the Biozentrum. In this interview, she talks about her childhood in the…

Oliver Biehlmaier, Head of Imaging Core Facility For 14 years, the Biozentrum has had its Imaging Core Facility (IMCF) – and for 14 years, it has been led by Oliver Biehlmaier. The IMCF was among the first technology…

IMCF OMERO Image Management System OMERO is a biological image data management system designed to support the vast amount of imaging data a scientist may work with and to provide easy ways of accessing, showing and working…

Bacteria are masters of survival. Pathogens, for example, produce a range of molecules enabling them to infect their hosts and to evade the immune defense. The entero-pathogenic bacterium Salmonella enterica Typhimurium uses…

Just a question of perspective June 2019 In Tanzania you can wait for five hours for a train and no one complains. In Sweden there is a two-month summer break. In Switzerland, in contrast, this time is used efficiently. The…

Interview with Chris Peyer At first he was surprised. He had imagined that studying biology would be different. It not only deals with the human being. On the contrary, it is exactly the broad range of fields, which he now…

The Biozentrum start-up Aukera Therapeutics was selected to join the BaseLaunch Accelerator Program. With its qualification for this program, the biotech venture receives funding of up to 500,000 Swiss francs as well as…